HQ Function

The headquarters serves as the company's primary center for research and development, 3D bioprinting operations, preclinical studies, clinical trial management, and corporate administration.

Notable Features:

Features state-of-the-art laboratory facilities specifically designed and equipped for advanced 3D bioprinting, cell biology, tissue engineering, and potentially cGMP (Current Good Manufacturing Practice) capabilities for producing clinical-grade living tissue implants.

Work Culture:

Characterized by a dynamic, innovative, and collaborative environment. The culture emphasizes cutting-edge science, interdisciplinary teamwork, and a strong mission-driven approach focused on translating scientific breakthroughs into tangible clinical solutions for patients.

HQ Significance:

The Long Island City headquarters is crucial to 3DBio's leadership in the field of 3D bioprinting for regenerative medicine. It houses the core technology, scientific expertise, and operational infrastructure driving their pioneering clinical programs and product development pipeline.

Values Reflected in HQ: The headquarters reflects values of innovation, scientific excellence, patient-centricity, and a pioneering spirit. The facility is designed to foster breakthrough research and development in a cutting-edge field of medicine.

Location:

While 3DBio Therapeutics is headquartered and primarily conducts its clinical operations in the United States, its pioneering work in 3D bioprinting and regenerative medicine has global implications. The company's research and therapeutic candidates aim to address unmet medical needs worldwide. Collaborations with international researchers and institutions may occur, and future expansion of clinical trials or commercialization efforts could extend their presence to other regions, pending regulatory approvals and strategic partnerships.

Street Address:

45-35 35th Street

City:

Long Island City

State/Province:

NY

Country:

USA